Gupta, R., Espinal, M., Beggs, A., Laing, R., Preger, J., Castro, K., Cegielski, J. P., De Luca, N., Laserson, K., Walton, W., Wells, C., Erokhin, V., Mishin, V., Vassilieva, I., Karataev, O. N., Drobniewski, F., Brander, L., Katila, M. L., Malakhov, I., Safonova, S., Sheyanenko, O., Starchenkova, N., Farmer, P., Hiatt, H., Kim, J., Mukherjee, J., Murray, M., Becerra, M., Nardell, E., Palmero, D. J., Bonilla, C., Solovic, I., Mahmud, A. M., Rahman, A., Melnyk, V. M., Portaels, F., Creach, P., Billo, N., Repina, E., Rakhishev, G., Pechiorina, I., Squire, Bertie ORCID: https://orcid.org/0000-0001-7173-9038, Coker, R., Arora, V. K., Sloutsky, A., Timperi, R., Henkens, M., Lafontaine, D., Slavuckij, A., Vezhnina, N., Cullinan, T., Healing, T., Weyer, K., Heifets, L., Iseman, M., Lee, D. H., Park, S. K., Chaulet, P., Gajardo, N. Z., Mata, Z., Danilovits, M., Vink, K., Khechinashvili, G., Louissant, M., Ismailov, S., Kibuga, D., Leimane, V., Davidaviciene, E., Ferreira, E., MacArthur, A., Bam, D. S., Alarcon, E., Suarez, P. G., De Marco, J. R., Reichmann, L. B., Salfinger, M., Hasler, T., Ovreberg, K., Ringdal, T., Garcia, J. B., Barry, D., Castro, A., Mitnick, C., Rich, M., Seung, K., Livchane, E., Passetchnikov, A., Ponomarenko, O., Trusov, A., Mariandyshev, A., Strelis, A. K., Lambregts-van Weezenbeek, C., Perelmann, M. I., Borstchevsky, V., Torun, T., Hoffner, S., Sillastu, H., Barid, S., Hinman, A. and Rosenberg, M. L. (2003) 'A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB) - Consensus statement'. International Journal of Tuberculosis and Lung Disease, Vol 7, Issue 5, pp. 410-414.
Full text not available from this repository.Item Type: | Article |
---|---|
Corporate Authors: | Stop TB Working Group on DOTS-Plus for MDR-TB |
Additional Information: | This ia a consensus statement drafted by Rajesh Gupta and Marcos Espinal on behalf of the Stop TB Working Group on DOTS-Plus for MDR-TB, listed in the Appendix. |
Subjects: | QW Microbiology and Immunology > QW 45 Microbial drug resistance. General or not elsewhere classified. WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General) WF Respiratory System > Tuberculosis > WF 360 Drug therapy |
Related URLs: | |
Depositing User: | Martin Chapman |
Date Deposited: | 17 Jan 2013 10:52 |
Last Modified: | 19 Nov 2024 13:44 |
URI: | https://archive.lstmed.ac.uk/id/eprint/2559 |
Statistics
Actions (login required)
Edit Item |